| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | Director | Stock option (right to buy) | 75,000 | 03 Sep 2025 | Direct | ||
| Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | 23 Jan 2024 | Direct | |
| Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | 23 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | 03 Sep 2025 | 1 | $0 | 4 | Director | 05 Sep 2025, 16:04 |
| CATX | Perspective Therapeutics, Inc. | 03 Sep 2025 | 0 | $0 | 3 | Director | 05 Sep 2025, 16:02 |
| MRTX | Mirati Therapeutics, Inc. | 23 Jan 2024 | 6 | $0 | 4 | Director | 23 Jan 2024, 20:37 |
| MRTX | Mirati Therapeutics, Inc. | 29 Dec 2023 | 1 | +$399,970 | 4 | Director | 03 Jan 2024, 18:32 |
| MRTX | Mirati Therapeutics, Inc. | 20 Jan 2023 | 2 | $0 | 4 | Director | 24 Jan 2023, 15:00 |
| MRTX | Mirati Therapeutics, Inc. | 14 Jan 2022 | 2 | $0 | 4 | Director | 18 Jan 2022, 17:20 |